shows reduced ability to promote this splicing event suggesting that recognition of the weak 3' splice site involves the U2AF heterodimer. Furthermore, our data suggest that rather then being required for splicing of all pre-mRNA substrates containing a weak polypyrimidine tract, U2AF 35 regulates selection of weak 3' splice sites in a specific subset of cellular transcripts.
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Cell culture, RNAi and transfection procedures
Human HeLa cells (ECACC 93021013) were grown as monolayers in minimum essential medium with Earle's salts (DMEM) supplemented with 10% (v/v) fetal calf serum and 1% (v/v) nonessential amino acids (Gibco, Invitrogen). When pBI constructs were used, 2µg/ml Doxycycline (Sigma) was added to the medium at the time of transfection. siRNA duplexes were synthesised as 21-mers with 3'dTdT overhangs (EUROGENTEC S.A.) (6) . The sequences of the oligonucleotides used for targeting U2AF 65 and U2AF 35 isoforms were as follows: h65: 5'-GCA CGG UGG ACU GAU UCG UdTdT-3' (GenBank acc. Number NM_007279, nt1271-nt1289);
h35a: 5'-CCA UUG CCC UCU UGA ACA UdTdT-3' (GenBank acc. number NM_006758, nt218-nt238), h35b: 5'-CCA UCU UGA UUC AAA ACA UdTdT-3' (GenBank acc. number AJ627978, nt164-nt182) and h35a&b: 5'-GGC UGU GAU UGA CUU GAA UdTdT -3'
(GenBank acc. number NM_006758, nt459-nt479). For siRNA transient transfection, 35-mm Petri dishes were seeded with 6x10 4 cells prior to the day of transfection. 150nM of each siRNA duplex
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Western Blot Analysis
Western blot analysis of transfected cells was performed using whole cell extracts that were prepared in SDS sample buffer as described (22). Lysates were boiled for 5 min and then fractionated by electrophoresis in either 10% or 12% SDS-polyacrylamide gel and transferred to nitrocellulose membranes by electroblotting. Western blotting was carried out by standard immunoblotting procedures. The following primary antibodies were used: mouse monoclonal antibodies directed against U2AF 65 (MC3 (8)), -actin (clone AC-15, Sigma), and FLAG epitope (M2, Sigma); and rabbit polyclonal serums directed against U2AF 35 (kindly provided by Angus Lamond (3)), and HA epitope (Y-11, Santa Cruz Biotech.). Immunoblots were developed using horseradish peroxidase-coupled secondary antibodies and detected by enhanced chemoluminescence (ECL; Amersham Biosciences).
RT-PCR and Real Time Quantitative PCR
Total RNA was extracted using the TRIzol reagent (Invitrogen), and treated with RNase-free DNase I (Roche Diagnostics). RT-PCR reactions were random primed and cDNA was produced using Superscript II Reverse Transcriptase (Invitrogen) according to the manufacturer's These results reveal a feedback mechanism by which depletion of the U2AF large subunit triggers the downregulation of the small subunit. Such a feedback loop is consistent with earlier studies indicating that U2AF heterodimer formation is essential for Drosophila viability (28) and ), and the 129-bp band corresponds to the use of the strong distal 3' splice site (PY).
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The ratio between the intensities of the bands corresponding to the py (Fig. 4C) . Most probably, the strongest effect on splicing observed in this experiment compared to the results depicted in Figure 3 correlates with the higher level of expression of the exogenous protein due to the use of different expression systems. In contrast to overexpression of full-length U2AF 65 , which caused a 5-fold increase in splicing of the weak splice site (Fig. 4C, 2) , overexpression of the mutant U2AF 65 35 induced only a 2-fold increase (Fig. 4C, 3) . Importantly, splicing of the strong 3' splice site was not inhibited by expression of U2AF 65 35 (Fig. 4B , compare PY in lanes 1 and 3), arguing that the reduced effect of this mutant on the weak site is not a consequence of its inability to support splicing. Taken together, our results support the view that the large subunit of the U2AF heterodimer cooperates with the small subunit to facilitate recognition of a weak 3' splice site in vivo. (Fig. 5A ). In one of them, both alternative 3' splice sites are associated with the strong AdML Polypyrimidine tract (PYPY). In the other, the two alternative 3' splice sites are associated to weak polypyrimidine tracts, due to replacement of all uridine residues in the strong AdML polypyrimidine tract by adenosines and guanidines (pypy The results obtained by semi-quantitative RT-PCR analysis shows that in GL2-treated cells one major mRNA band is observed corresponding to splicing of the proximal site in both reporters ( Fig. 5B and C, lane 1) . Thus, in the two transcripts containing alternative 3' splice sites associated with polypyrimidine tracts of similar strength, there is a strong preference for splicing of the proximal site irrespective of it being weak or strong. This is in agreement with previous studies showing that in model human -globin pre-mRNAs containing a single 5' splice site and tandemly duplicated 3' splice sites, the proximal 3' site is preferentially selected (26). 
U2AF-dependent and U2AF-independent recognition of alternative 3' splice sites in endogenous pre-mRNAs
To determine whether U2AF plays a role in alternative splicing of endogenous premRNAs, we performed a bioinformatics search for human transcripts containing alternative 3' splice sites of different strength. First, we searched for genes that contain a proximal 3' splice site associated to a weak polypyrimidine tract and a distal 3' splice site associated to a strong polypyrimidine tract. A 3' splice site was considered 'strong' if it contained four consecutive T further searched for candidates with a potential enhancer in the sequence comprised between the two alternate 3' splice sites. The selection of candidates was therefore restricted to pre-mRNAs containing at least one GAA motif (1) within 20 to ~300 nucleotides downstream of the proximal 3' splice site (Fig. 6A ). Using these criteria we identified 70 candidate pre-mRNAs (supplementary Table 2 ) corresponding to diverse functional groups such as cell proliferation and apoptosis genes, signal transduction and transcription regulators, or metabolic pathways components. From this candidate list, 8 genes were randomly chosen for validation (Fig. 6B) , and only four (CUEDC1, EIF3S7, MBNL3 and PTK9) were found to be alternatively spliced in HeLa cells producing the predicted isoforms (Fig. 7A) . Following knockdown of U2AF proteins, splicing of the weak proximal site was significantly reduced in CUEDC1 and EIF3S7 mRNAs, but not in MBNL3 or PTK9 transcripts (Fig. 7B) . Noteworthy, for both CUEDC1 and EIF3S7 mRNAs the major isoform detected in non-treated cells corresponds to splicing of the stronger distal site, whereas for MBNL3 and PTK9 splicing of the proximal site predominates (Fig. 7A) . We therefore speculate that MBNL3 and PTK9 pre-mRNAs contain additional specific elements that stimulate splicing of the weaker 3' site in a U2AF-independent manner. In conclusion, and in agreement with the results obtained with the reporter minigenes, the data strongly suggest that U2AF regulates splicing of a subset of endogenous pre-mRNAs containing alternative 3' splice sites associated with polypyrimidine tracts of different strength. 
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Zuo, P., and T. Maniatis. 1996. The splicing factor U2AF35 mediates critical proteinprotein interactions in constitutive and enhancer-dependent splicing. Genes Dev 10:1356-68. and PY isoforms. The ratio between isoform levels (py/PY) was calculated from the formula 2 -Ct , relative to the ratio present on cells transfected with empty vector (-). Results are presented as means ± SD for at least four independent experiments; *, p<0.05 relative to control (-) (Mann-Whitney U Test). Table 1 ). The ratio between isoform levels (Prox 
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